Literature DB >> 32891354

Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.

E O'Connell1, I S Reynolds2, D A McNamara3, J H M Prehn4, J P Burke5.   

Abstract

BACKGROUND: Response to neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer is variable. Identification of biomarkers to predict response is desirable in order to provide prognostic information and targeted therapy. Several studies have investigated microsatellite instability (MSI) as a predictor of response to CRT with contradictory results. This study aims to clarify the effect of MSI status on response to CRT in locally advanced rectal cancer through systematic review and meta-analysis.
METHODS: A systematic search of PubMed, Embase and Cochrane databases was performed for all studies relating to MSI and response to CRT in rectal cancer using the search algorithm (Microsatellite Instability) AND (Chemoradiotherapy) AND (Rectal Cancer). From each included study the number of patients with MSI tumors and Microsatellite Stable (MSS) tumors and the numbers achieving pathological complete response (pCR) were recorded. Pooled outcome measures were determined using a random effects model and the odds ratio estimated with variance and 95% confidence interval.
RESULTS: Nine published studies were identified reporting data on MSI and its effect on outcome after CRT for locally advanced rectal cancer. Five studies describing 5,877 patients included data on MSI and the number of patients achieving pCR. There was no significant association between MSI and pCR (MSI Vs MSS: 10.1% Vs 6.6%, OR 1.38, 95% CI: 0.7-2.72, p = 0.35).
CONCLUSION: This meta-analysis concludes that there appears to be no significant difference in pCR rate following CRT in patients with MSI versus MSS rectal tumors.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Microsatellite instability; Neoadjuvant chemoradiotherapy; Pathological complete response; Rectal cancer

Mesh:

Year:  2020        PMID: 32891354     DOI: 10.1016/j.suronc.2020.03.009

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  8 in total

Review 1.  Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.

Authors:  Hsin-Hua Lee; Chien-Hung Chen; Yu-Hsiang Huang; Cheng-Han Chiang; Ming-Yii Huang
Journal:  Cells       Date:  2022-05-11       Impact factor: 7.666

Review 2.  Microsatellite instability and chemosensitivity in solid tumours.

Authors:  Sara Cherri; Ester Oneda; Silvia Noventa; Laura Melocchi; Alberto Zaniboni
Journal:  Ther Adv Med Oncol       Date:  2022-05-21       Impact factor: 5.485

3.  Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Anup Kasi; Saqib Abbasi; Shivani Handa; Raed Al-Rajabi; Anwaar Saeed; Joaquina Baranda; Weijing Sun
Journal:  JAMA Netw Open       Date:  2020-12-01

4.  Association between microsatellite instability and tumor response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Soo Young Lee; Duck-Woo Kim; Jaram Lee; Hyeong-Min Park; Chang Hyun Kim; Kyung-Hwa Lee; Heung-Kwon Oh; Sung-Bum Kang; Hyeong Rok Kim
Journal:  Ann Surg Treat Res       Date:  2022-09-06       Impact factor: 1.766

5.  Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.

Authors:  Junbo Xiao; Xiaotong Wang; Yajun Liu; Xiaowei Liu; Jun Yi; Jiuye Hu
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

6.  Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy.

Authors:  Soo-Yoon Sung; Sea-Won Lee; Ji Hyung Hong; Hye Jin Kang; So Jung Lee; Myungsoo Kim; Ji-Hoon Kim; Yoo-Kang Kwak
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

7.  Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature.

Authors:  Marloes Swets; Cristina Graham Martinez; Shannon van Vliet; Arjan van Tilburg; Hans Gelderblom; Corrie A M Marijnen; Cornelis J H van de Velde; Iris D Nagtegaal
Journal:  Histopathology       Date:  2022-07-14       Impact factor: 7.778

Review 8.  Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients.

Authors:  Aylin Alkan; Tobias Hofving; Eva Angenete; Ulf Yrlid
Journal:  Biomark Res       Date:  2021-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.